News

BioCarrier cases will provide regular route, multiple site sample collection and "home visit" temperature-sensitive injectable drug protection. Intelsius CEO David Walsh said that the company is introducing the

As per the agreement, AMRI may supply a range of services from drug discovery to cGMP manufacturing. The two companies have already agreed to collaborate on hit-to-lead and

The plan was announced along with the company’s first-quarter results that revealed the sales drop by 3% compared to previous year. According to GSK, the decision to pursue

Qualiphi is an upgraded version of the Phi 29 DNA polymerase used in isothermal amplification, which offers improved properties. Sygnis CEO Pilar de la Huerta said that the

As part of the funding, IRICoR along with MaRS Innovation and the Centre for Drug Research and Development (CDRD) will identify, develop and commercialize technologies in healthcare. Merck

The assays are used to determine hemoglobin variants and diabetes risk, using Bruker´s Matrix-Assisted Laser Desorption Ionization (MALDI) Biotyper platform for clinical mass spectrometry and based on intellectual

BD Simplist prefilled injectables are designed to enhance patient care and safety by minimizing the number of steps in the traditional vial and syringe injection sequence, cutting the

Of €3.6m, €2.7m will be used for balance sheet restructuring and €0.9m will finance the additional production facilities. Piramida CEO Kresimir Hlede said that the investment would mark

The multi-centre study will determine a recommended NEOD001 dose for testing in Phase 2 trials. Prothena president and chief executive officer Dale Schenk said preclinical data indicated NEOD001’s